FDA Inspection 1080931 — Gustavo Daniel Lopardo, M.D.
The FDA completed an inspection of Gustavo Daniel Lopardo, M.D. on Feb 20, 2019 in Ciudad Autonoma Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 20, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ciudad Autonoma Buenos Aires (Argentina)
Additional details
Clinical Investigator (CI)